Publications by authors named "Canfeng He"

Non-small-cell lung cancer (NSCLC) is one of the most prevalent cancers worldwide. A Yi-Fei-San-Jie formula (YFSJF), widely used in NSCLC treatment in south China, has been validated in clinical studies. However, the pharmacological mechanism behind it remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • Long non-coding RNAs (lncRNAs) are being studied for their potential as biomarkers in lung cancer, yet their relationship with genomic instability and the tumor immune microenvironment remains underexplored in non-small cell lung cancer (NSCLC).
  • A study utilized data from The Cancer Genome Atlas (TCGA) to identify a signature of 11 genomic instability-related lncRNAs (GIrLncSig) and performed various analyses to understand their functions and impact on patient prognoses.
  • The findings showed that patients classified into low-risk groups based on the GIrLncSig had significantly better overall survival rates compared to high-risk patients, highlighting the signature's independent prognostic value and its potential to enhance predictions when combined with
View Article and Find Full Text PDF

Background: Acneiform eruptions from epidermal growth factor receptor tyrosine kinase inhibitors is a frequent adverse event in non-small cell lung cancer patients but the efficacy of its treatment including antibiotics, corticosteroid, sunscreen is still poorly understood.

Methods: Eight electronic databases (PubMed, EMBASE, ClinicalTrials.gov, etc) will be searched from inception to April 2020.

View Article and Find Full Text PDF

Background: Septic shock is a serious disease with high morbidity, which will lead to organ dysfunction. Shen fu injection (SFI) has been widely used for septic shock as a treatment in China. Many clinical trials have been reported that it could assess the efficacy and safety of SFI to cure septic shock and accelerate resuscitation.

View Article and Find Full Text PDF